Clariant Geçmiş Kazanç Performansı
Hala bu şirketin son kazanç raporunu inceliyoruz
Geçmiş kriter kontrolleri 0/6
Clariant şirketinin kazançları yıllık ortalama -14% oranında azalırken, Chemicals sektörünün kazançları yıllık 0.2% oranında artan oldu. Gelirler yıllık ortalama 1% oranında azalan oldu.
Anahtar bilgiler
-14.02%
Kazanç büyüme oranı
-13.98%
EPS büyüme oranı
| Chemicals Sektör Büyümesi | 5.98% |
| Gelir büyüme oranı | -1.04% |
| Özkaynak getirisi | -1.88% |
| Net Marj | -1.92% |
| Sonraki Kazanç Güncellemesi | 31 Jul 2026 |
Yakın geçmiş performans güncellemeleri
Recent updates
Anlatı Güncellemesi • May 02
CLN: Trimmed Assumptions And Downgrades Will Shape Measured Forward Expectations
Analysts have trimmed their price target on Clariant by CHF 0.09 to reflect updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, in line with recent research that includes a downgrade from some firms. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as more realistic.
Anlatı Güncellemesi • Apr 17
CLN: Earnings Quality And Steadier Cash Generation Will Support Bullish Re Rating
Analysts have trimmed their price target on Clariant to CHF 12.37 from CHF 12.77, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E following recent research, including a downgrade from Goldman Sachs. Analyst Commentary While the latest research includes a downgrade from Goldman Sachs, some views across the Street remain constructive, focusing on how Clariant could still convert its fundamentals into long term value creation.Anlatı Güncellemesi • Apr 03
CLN: Recent Downgrade And Trimmed Assumptions Will Shape Potential Upside
Analysts have trimmed their CHF price targets for Clariant by a small amount, reflecting more cautious assumptions on revenue growth and profit margins. They are still applying a slightly higher future P/E multiple in their updated models.
Anlatı Güncellemesi • Mar 20
CLN: Lower CHF 7.80 Outlook Will Restrain Upside As Legal Claims Persist
Analysts have trimmed their average price target on Clariant to CHF 7.80 from CHF 8.00, reflecting slightly softer expectations that align with recent downgrades and more cautious assumptions on growth and returns. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the latest moves reflecting concerns around execution, growth visibility and how the current share price lines up with those risks.Anlatı Güncellemesi • Mar 05
CLN: Legal Claims And Recent Downgrade Will Frame Potential Upside Ahead
Analysts have trimmed their price expectations for Clariant, with the average target moving modestly lower to around CHF 7.80. This reflects updated assumptions on fair value, discount rates and future P/E in light of recent research calls.Anlatı Güncellemesi • Feb 19
CLN: Legal Claims And Rating Downgrade Will Shape Measured Future Upside Potential
The updated analyst price target for Clariant now stands at CHF 8.80, a small change from the prior CHF 8.74, as analysts factor in recent target cuts around CHF 7.80 and adjust their assumptions on discount rates, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts see the updated CHF 8.80 target as reflecting a more refined view of discount rates and earnings power, rather than a fundamental shift in the story.Anlatı Güncellemesi • Feb 05
CLN: Lower CHF 7.80 Outlook Will Cap Upside As Legal Claims Linger
Analysts have reduced their price target on Clariant to CHF 7.80 from CHF 8.00 to reflect updated views on the company’s discount rate, revenue growth assumptions, profit margins and future P/E. Analyst Commentary Bearish analysts are signaling a more cautious stance on Clariant by aligning their valuation work with a CHF 7.80 price level.Anlatı Güncellemesi • Jan 22
CLN: Revised Expectations And Legal Claims Will Shape Future Upside Potential
Analysts have reduced their price target for Clariant to CHF 7.80 from CHF 8.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the price target trimmed to CHF 7.80 from CHF 8 and the rating held steady at Hold.Anlatı Güncellemesi • Jan 07
CLN: Legal Claims And Steady Earnings Outlook Will Support Bullish Re Rating
Analysts have trimmed their price target on Clariant to CHF 7.80, reflecting updated assumptions for fair value, revenue growth, margins and future P/E multiples following recent research. Analyst Commentary Recent research points to a more measured stance on Clariant, with the revised CHF 7.80 target reflecting updated views on valuation, earnings power and the multiples investors might be willing to pay for the shares.Anlatı Güncellemesi • Dec 21
CLN: Reduced Price Outlook Will Limit Upside Amid Rising Legal Risks
Analysts have reduced their price target on Clariant by CHF 1.50 to CHF 8.10, reflecting more cautious assumptions on revenue growth and valuation multiples, even though margin expectations have improved slightly. Analyst Commentary Bearish analysts have framed the lower price target as a reflection of rising skepticism around Clariant's ability to deliver on its medium term growth ambitions, despite recent progress on margins.Anlatı Güncellemesi • Dec 07
CLN: Margin Recovery And Legal Overhang Will Shape Future Share Resilience
Analysts have trimmed their price target on Clariant by CHF 1.50 to reflect a slightly lower assumed future price to earnings multiple and discount rate, even as forecasts for profit margins have improved. Analyst Commentary Analysts remain balanced in their view on Clariant, with modest adjustments to valuation assumptions reflecting both improving profitability and lingering execution risks.Anlatı Güncellemesi • Nov 23
CLN: Market Recovery And Margin Discipline Will Drive Future Share Resilience
Clariant's analyst price target has been revised downward from CHF 9.78 to CHF 9.51. Analysts cite tempered expectations for near-term performance amid evolving market conditions.Anlatı Güncellemesi • Nov 07
CLN: Margin Improvements And Efficiency Efforts Will Offset Market Headwinds
Analysts have reduced their price target for Clariant from CHF 9.60 to CHF 8.10. This adjustment reflects lowered growth expectations and a more cautious outlook on the company's future performance.Analiz Makalesi • Nov 04
Cautious Investors Not Rewarding Clariant AG's (VTX:CLN) Performance Completely
There wouldn't be many who think Clariant AG's ( VTX:CLN ) price-to-earnings (or "P/E") ratio of 20.4x is worth a...Anlatı Güncellemesi • Oct 24
Earnings Recovery Will Depend On Stabilization And Cost Improvements Amid Headwinds
Narrative Update: Clariant Analyst Price Target Adjustment Clariant’s analyst price target has been reduced significantly, dropping from CHF 9.60 to CHF 8.10. Analysts cite softer revenue growth and profit margin expectations in their revised outlook.Anlatı Güncellemesi • Oct 10
China Expansion And Sustainable Solutions Will Boost Long-Term Appeal
Narrative Update on Clariant Clariant's analyst price target has been revised downward from CHF 10.95 to CHF 10.58. Analysts cite a combination of cautious revenue growth assumptions and a recent reduction in price targets by major banks.Anlatı Güncellemesi • Sep 26
China Expansion And Sustainable Solutions Will Boost Long-Term Appeal
The minor decrease in Clariant's price target reflects a combination of lower revenue growth expectations and a modestly higher discount rate, resulting in a slight fair value reduction to CHF10.95. What's in the News Clariant AG dropped from the FTSE All-World Index (USD).Analiz Makalesi • Sep 17
Is Clariant AG (VTX:CLN) Trading At A 32% Discount?
Key Insights Clariant's estimated fair value is CHF11.89 based on 2 Stage Free Cash Flow to Equity Current share price...Analiz Makalesi • Aug 26
We Think Clariant (VTX:CLN) Is Taking Some Risk With Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analiz Makalesi • Aug 08
Clariant's (VTX:CLN) Anemic Earnings Might Be Worse Than You Think
SWX:CLN 1 Year Share Price vs Fair Value Explore Clariant's Fair Values from the Community and select yours Clariant...Analiz Makalesi • May 30
Clariant (VTX:CLN) Has Affirmed Its Dividend Of CHF0.42
Clariant AG ( VTX:CLN ) has announced that it will pay a dividend of CHF0.42 per share on the 4th of June. Based on...Analiz Makalesi • May 05
These 4 Measures Indicate That Clariant (VTX:CLN) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analiz Makalesi • Apr 13
Are Investors Undervaluing Clariant AG (VTX:CLN) By 39%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Clariant fair value estimate is CHF13.37 Current share price...Analiz Makalesi • Mar 26
Clariant AG's (VTX:CLN) CEO Might Not Expect Shareholders To Be So Generous This Year
Key Insights Clariant's Annual General Meeting to take place on 1st of April Salary of CHF1.20m is part of CEO Conrad...Analiz Makalesi • Mar 05
Clariant AG Just Missed EPS By 6.0%: Here's What Analysts Think Will Happen Next
It's been a sad week for Clariant AG ( VTX:CLN ), who've watched their investment drop 10% to CHF9.76 in the week since...Analiz Makalesi • Mar 02
Take Care Before Diving Into The Deep End On Clariant AG (VTX:CLN)
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") above 21x, you may consider...
Yeni Anlatı • Dec 18
Restructuring, Lucas Meyer Cosmetics, And Sunliquid Set To Boost Margins And Drive Earnings
Identifying restructuring opportunities and targeting significant savings could improve Clariant's net margins and earnings efficiency in the coming years.Analiz Makalesi • Nov 27
Estimating The Intrinsic Value Of Clariant AG (VTX:CLN)
Key Insights The projected fair value for Clariant is CHF10.85 based on 2 Stage Free Cash Flow to Equity Clariant's...Analiz Makalesi • Nov 09
It's A Story Of Risk Vs Reward With Clariant AG (VTX:CLN)
Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now...Analiz Makalesi • Aug 07
Clariant's (VTX:CLN) Solid Earnings Have Been Accounted For Conservatively
The stock was sluggish on the back of Clariant AG's ( VTX:CLN ) recent earnings report. Our analysis suggests that...Analiz Makalesi • Jul 17
Why Investors Shouldn't Be Surprised By Clariant AG's (VTX:CLN) Low P/S
Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 1.1x might make it look like a strong buy right now...Analiz Makalesi • Apr 23
What Is Clariant AG's (VTX:CLN) Share Price Doing?
Clariant AG ( VTX:CLN ), might not be a large cap stock, but it received a lot of attention from a substantial price...Analiz Makalesi • Apr 03
Increases to Clariant AG's (VTX:CLN) CEO Compensation Might Cool off for now
Key Insights Clariant to hold its Annual General Meeting on 9th of April Total pay for CEO Conrad Keijzer includes...Analiz Makalesi • Nov 22
An Intrinsic Calculation For Clariant AG (VTX:CLN) Suggests It's 50% Undervalued
Key Insights The projected fair value for Clariant is CHF25.95 based on 2 Stage Free Cash Flow to Equity Current share...Analiz Makalesi • Oct 31
Clariant (VTX:CLN) Takes On Some Risk With Its Use Of Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analiz Makalesi • Jul 30
Clariant (VTX:CLN) Seems To Use Debt Quite Sensibly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Gelir ve Gider Dağılımı
Gelir ve Gider Dağılımı
Clariant nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 31 Dec 25 | 3,915 | -75 | 717 | 121 |
| 30 Sep 25 | 3,989 | 19 | 777 | 128 |
| 30 Jun 25 | 4,063 | 113 | 820 | 134 |
| 31 Mar 25 | 4,108 | 179 | 779 | 131 |
| 31 Dec 24 | 4,152 | 244 | 754 | 128 |
| 30 Jun 24 | 4,163 | 118 | 697 | 133 |
| 31 Mar 24 | 4,270 | 143 | 668 | 136 |
| 31 Dec 23 | 4,377 | 168 | 639 | 138 |
| 30 Jun 23 | 4,919 | -98 | 677 | 142 |
| 31 Mar 23 | 5,059 | -115 | 711 | 146 |
| 31 Dec 22 | 5,198 | -133 | 745 | 150 |
| 30 Sep 22 | 5,050 | 107 | 725 | 154 |
| 30 Jun 22 | 4,901 | 346 | 705 | 157 |
| 31 Mar 22 | 4,637 | 305 | 700 | 157 |
| 31 Dec 21 | 4,372 | 263 | 694 | 156 |
| 30 Sep 21 | 4,161 | 199 | 672 | 158 |
| 30 Jun 21 | 3,949 | 135 | 649 | 159 |
| 31 Mar 21 | 3,905 | 121 | 665 | 159 |
| 31 Dec 20 | 3,860 | 106 | 681 | 159 |
| 30 Jun 20 | 4,115 | 141 | 1,010 | 166 |
| 31 Mar 20 | 4,257 | 40 | 1,019 | 171 |
| 31 Dec 19 | 4,399 | -62 | 1,027 | 175 |
| 30 Jun 19 | 4,409 | -67 | 865 | 176 |
| 31 Mar 19 | 4,407 | 64 | 861 | 175 |
| 31 Dec 18 | 4,404 | 194 | 856 | 174 |
| 30 Sep 18 | 4,937 | 223 | 922 | 182 |
| 30 Jun 18 | 5,469 | 251 | 987 | 190 |
| 31 Mar 18 | 5,923 | 264 | 1,072 | 197 |
| 31 Dec 17 | 6,377 | 277 | 1,157 | 203 |
| 30 Sep 17 | 6,229 | 276 | 1,130 | 201 |
| 30 Jun 17 | 6,080 | 274 | 1,102 | 199 |
| 31 Mar 17 | 5,964 | 264 | 1,093 | 199 |
| 31 Dec 16 | 5,847 | 253 | 1,084 | 199 |
| 30 Sep 16 | 5,899 | 211 | 1,083 | 208 |
| 30 Jun 16 | 5,835 | 203 | 1,092 | 208 |
| 31 Mar 16 | 5,792 | 195 | 1,063 | 207 |
| 31 Dec 15 | 5,807 | 217 | 1,067 | 204 |
| 30 Sep 15 | 5,867 | 275 | 1,064 | 199 |
| 30 Jun 15 | 5,964 | 272 | 1,061 | 203 |
Kaliteli Kazançlar: CLN şu anda kârlı değil.
Büyüyen Kar Marjı: CLN şu anda kârlı değil.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: CLN kârlı değildir ve zararlar son 5 yılda yılda 14% oranında artmıştır.
Büyüme Hızlandırma: CLN 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil
Kazançlar vs. Sektör: CLN kârlı olmadığından, geçmiş yıl kazanç büyümesinin Chemicals sektörüyle ( -1.3% ) karşılaştırılması zorlaşıyor.
Özkaynak Getirisi
Yüksek ROE: CLN hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -1.88% ) sahiptir.
Varlık Getirisi
Kullanılan Sermaye Getirisi
Geçmişte güçlü performans gösteren şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/20 15:30 |
| Gün Sonu Hisse Fiyatı | 2026/05/20 00:00 |
| Kazançlar | 2025/12/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Clariant AG 35 Bu analistlerden 15, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Katie Richards | Barclays |